The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000527.5(LDLR):c.1204TTC[1] (p.Phe403del)

CA10585356

251731 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial (MONDO:0007750)
Inheritance Mode: Semidominant inheritance
UUID: 5f27e072-31eb-415e-a56b-be4715f15dab
Approved on: 2023-01-27
Published on: 2024-10-07

HGVS expressions

NM_000527.5(LDLR):c.1204TTC[1] (p.Phe403del)
NM_000527.5:c.1204TTC[1]
NC_000019.10:g.11113298_11113300del
CM000681.2:g.11113298_11113300del
NC_000019.9:g.11223974_11223976del
CM000681.1:g.11223974_11223976del
NC_000019.8:g.11084974_11084976del
NG_009060.1:g.28918_28920del
ENST00000252444.10:c.1465_1467del
ENST00000559340.2:c.1207_1209del
ENST00000560467.2:c.1087_1089del
ENST00000558518.6:c.1207_1209del
ENST00000252444.9:c.1461_1463del
ENST00000455727.6:c.703_705del
ENST00000535915.5:c.1084_1086del
ENST00000545707.5:c.826_828del
ENST00000557933.5:c.1207_1209del
ENST00000558013.5:c.1207_1209del
ENST00000558518.5:c.1207_1209del
ENST00000560173.1:n.206_208del
ENST00000560467.1:c.687_689del
NM_000527.4:c.1207_1209del
NM_001195798.1:c.1207_1209del
NM_001195799.1:c.1084_1086del
NM_001195800.1:c.703_705del
NM_001195803.1:c.826_828del
NM_000527.5:c.1207_1209del
NM_001195798.2:c.1207_1209del
NM_001195799.2:c.1084_1086del
NM_001195800.2:c.703_705del
NM_001195803.2:c.826_828del
More

Likely Pathogenic

Met criteria codes 4
PP4 PM4 PM2 PS4_Supporting
Not Met criteria codes 16
PS2 PS1 PS3 BA1 PP1 PP3 PM3 PM1 PM5 PM6 BS4 BS3 BS1 BS2 BP5 BP2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.1207_1209del (p.Phe403del) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2, PM4, PP4 and PS4_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 27 January 2023. The supporting evidence is as follows: PM2: This variant is absent from gnomAD (v2.1.1). PM4: Variant meets PM2 and is an in-frame deletion. PS4_Supporting, PP4: Variant meets PM2 and was identified in at least 5 unrelated index cases who fulfill criteria for FH (4 patients from PMID 22698793 (Tichý et al., 2012) and 1 patient from PMID 11462246 (Nauck et al., 2001), reported as 1205delTCT).
Met criteria codes
PP4
PP4 - Variant meets PM2 and was identified in at least 5 patients meeting clinical FH criteria (PMID: 22698793 and PMID 11462246), after alternative causes of high cholesterol were excluded.
PM4
PM4 - Variant meets PM2 and is an in frame deletion.
PM2
PM2 - Variant is absent from gnomAD (v2.1.1).
PS4_Supporting
PS4_Supporting - Variant meets PM2 and was identified in 4 patients (PMID: 22698793) with MEDPED score of FH and and in 1 patient (PMID 11462246) reported as 1205delTCT with TC 10.33 and LDL-C 8.03.
Not Met criteria codes
PS2
No de novo cases were identified.
PS1
Not applicable
PS3
There is no functional evidence in ClinVar for this variant
BA1
Variant is absent from gnomAD (v2.1.1).
PP1
PP1 - no information or report of segregation data/cases
PP3
PP3 - No REVEL (not a missense variant). In silico prediction/evaluation (MaxEnsScan) is not recommended for indels.
PM3
Variant meets PM2 but is not identified in an index case with heterozygous or homozygous FH phenotype as well as LDLR variant, in trans, or APOB/PCSK9 variant classified as Pathogenic by these or general ACMG guidelines.
PM1
PM2 is Met, but variant is not a missense in exon 4 or any of the 60 Cys residues listed. Not applicable.
PM5
Not applicable
PM6
No de novo cases were identified.
BS4
No information or report of segregation data/cases
BS3
There is no functional evidence in ClinVar for this variant
BS1
Variant is absent from gnomAD (v2.1.1).
BS2
Variant not identified in normolipidemic individuals
BP5
not applicable
BP2
Variant meets PM2 but is not identified in an index case with heterozygous or homozygous FH phenotype as well as LDLR variant, in trans, or APOB/PCSK9 variant classified as Pathogenic by these or general ACMG guidelines.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.